BioMarin Pharmaceutical
BMRN
#1765
Rank
โ‚น1.080 T
Marketcap
โ‚น5,617
Share price
0.91%
Change (1 day)
-9.20%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: โ‚น1.080 Trillion

As of March 2026 BioMarin Pharmaceutical has a market cap of โ‚น1.080 Trillion. This makes BioMarin Pharmaceutical the world's 1765th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 1999 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น1.080 T4.48%
2025โ‚น1.033 T-5.46%
2024โ‚น1.093 T-27.67%
2023โ‚น1.512 T-5%
2022โ‚น1.591 T31.83%
2021โ‚น1.207 T3.71%
2020โ‚น1.164 T7.37%
2019โ‚น1.084 T2.17%
2018โ‚น1.061 T6.14%
2017โ‚น999.91 B3.28%
2016โ‚น968.18 B-13.9%
2015โ‚น1.124 T31.64%
2014โ‚น854.21 B37%
2013โ‚น623.52 B83.98%
2012โ‚น338.91 B63.16%
2011โ‚น207.72 B55.59%
2010โ‚น133.50 B51.51%
2009โ‚น88.11 B3.17%
2008โ‚น85.40 B-36.7%
2007โ‚น134.91 B102.63%
2006โ‚น66.58 B84.73%
2005โ‚น36.04 B101.93%
2004โ‚น17.84 B-21.25%
2003โ‚น22.66 B24.66%
2002โ‚น18.18 B-46.49%
2001โ‚น33.98 B103.56%
2000โ‚น16.69 B-6.17%
1999โ‚น17.79 B

End of Day market cap according to different sources

On Mar 5th, 2026 the market cap of BioMarin Pharmaceutical was reported to be:

โ‚น1.070 Trillion
by Nasdaq info icon info icon
โ‚น1.070 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
โ‚น9.887 T 815.30%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
โ‚น188.69 B-82.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น12.89 B-98.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น59.75 B-94.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น413.78 B-61.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น273.79 B-74.65%๐Ÿ‡บ๐Ÿ‡ธ USA